PUNE, India, Oct. 27, 2023 /PRNewswire/ -- Infinium Global Research, a prominent market research firm, has recently published a comprehensive report on the Gastroparesis Treatment Market. The report offers an in-depth analysis of various segments and sub-segments in the global and regional gastroparesis treatment market, providing valuable insights into market trends, forecasts, and dollar values. The global gastroparesis treatment market was valued at USD 8.20 Billion in 2022 and is expected to reach USD 11.09 Billion by 2030 and grow at a CAGR of 3.3% over the forecast period.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1382
Gastroparesis, a debilitating condition characterized by delayed stomach emptying, is most commonly associated with diabetes. High blood glucose levels can lead to nerve chemical alterations and harm to blood vessels supplying nerves with oxygen and nutrients. Additionally, Idiopathic Gastroparesis (IG), a condition with various potential causes, further emphasizes the need for effective treatments. Patients with IG may experience nerve damage, muscle problems, or other medical conditions, such as scleroderma, amyloidosis, and lupus, making effective Gastroparesis treatment imperative.
The report underscores the rising prevalence of diabetes and idiopathic gastroparesis, particularly among the elderly population, as a significant driver for the expansion of the Gastroparesis Treatment Market. The aging demographic faces challenges in oral medication absorption, appetite regulation, and post-meal blood sugar fluctuations, creating a demand for effective treatments. However, it's important to note that the use of Gastroparesis drugs may come with side effects, including fatigue, nausea, vomiting, sleepiness, depression, anxiety, and physical movement problems. These side effects may hinder market growth, but the emergence of personalized treatment approaches offers the potential to mitigate these challenges, making treatments more tolerable for patients.
North America Leads the Gastroparesis Treatment Market in Terms of Revenue
North America holds the largest market share in the Gastroparesis Treatment Market, primarily due to its advanced healthcare infrastructure, robust research and development initiatives, and well-established reimbursement systems. The region's high prevalence of gastroparesis cases, often linked to conditions like diabetes and post-surgical complications, further drives demand for effective therapies. Additionally, the growing aging population's susceptibility to gastroparesis and the increasing focus on healthcare technologies contribute to North America's dominant position in the Gastroparesis Treatment Market.
Asia Pacific Emerges as the Fastest-Growing Market
In contrast, the Asia Pacific region has emerged as the fastest-growing market for Gastroparesis treatment. Rapid urbanization and economic growth have contributed to this growth. For instance, India has witnessed an increase in gastroparesis cases, particularly diabetes-related gastroparesis, due to changing dietary habits. Pharmaceutical companies are expanding their presence in Asia Pacific, providing innovative treatments and meeting the rising demand for Gastroparesis treatment in the region.
Segmentation and Company Profiles
The report on the global gastroparesis treatment market covers various segments, including type, drug class, treatment, and distribution channel. On the basis of type, the sub-markets include diabetic, idiopathic, post-surgical, and others. On the basis of drug class, the sub-markets include prokinetic drugs, antiemetics, botulinum toxin injection, antidepressants, and others. On the basis of treatment, the sub-markets include jejunostomy, gastric electric stimulation, parenteral nutrition, diabetic gastroparesis, post-operative gastroparesis, and others. On the basis of distribution channel, the sub-markets include retail pharmacies, hospital pharmacies, and others.
Companies profiled in the report include Medtronic, Neurogastrx, Inc., Endologic, Takeda Pharmaceutical Company Limited, Theravance Biopharma, EVOKE PHARMA, Cedars-Sinai, GSK plc, CinDome Pharma, Inc., and Processa Pharmaceuticals, Inc.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/1382
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Gastroparesis Treatment Market Highlights
2.2. Gastroparesis Treatment Market Projection
2.3. Gastroparesis Treatment Market Regional Highlights
Chapter 3. Global Gastroparesis Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Type
3.4.2. IGR-Growth Matrix Analysis by Drug Class
3.4.3. IGR-Growth Matrix Analysis by Treatment
3.4.4. IGR-Growth Matrix Analysis by Distribution Channel
3.4.5. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Gastroparesis Treatment Market
Chapter 4. Gastroparesis Treatment Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Gastroparesis Treatment Market
5.2. Companies Profiles
5.2.1. Medtronic
5.2.2. Neurogastrx, Inc.
5.2.3. Endologic
5.2.4. Takeda Pharmaceutical Company Limited
5.2.5. Theravance Biopharma
5.2.6. EVOKE PHARMA
5.2.7. Cedars-Sinai
5.2.8. GSK plc
5.2.9. CinDome Pharma, Inc.
5.2.10. Processa Pharmaceuticals, Inc.
Chapter 6. Global Gastroparesis Treatment Market by Type
6.1. Diabetic
6.2. Idiopathic
6.3. Post-surgical
6.4. Others
Chapter 7. Global Gastroparesis Treatment Market by Drug Class
7.1. Prokinetic Drugs
7.2. Antiemetics
7.3. Botulinum Toxin Injection
7.4. Antidepressants
7.5. Others
Chapter 8. Global Gastroparesis Treatment Market by Treatment
8.1. Jejunostomy
8.2. Gastric Electric Stimulation
8.3. Parenteral Nutrition
8.4. Diabetic Gastroparesis
8.5. Post-operative Gastroparesis
8.6. Others
Chapter 9. Global Gastroparesis Treatment Market by Distribution Channel
9.1. Retail Pharmacies
9.2. Hospital Pharmacies
9.3. Others
Chapter 10. Global Gastroparesis Treatment Market by Region 2023-2030
10.1. North America
10.1.1. North America Gastroparesis Treatment Market by Type
10.1.2. North America Gastroparesis Treatment Market by Drug Class
10.1.3. North America Gastroparesis Treatment Market by Treatment
10.1.4. North America Gastroparesis Treatment Market by Distribution Channel
10.1.5. North America Gastroparesis Treatment Market by Country
10.1.5.1. The U.S. Gastroparesis Treatment Market
10.1.5.1.1. The U.S. Gastroparesis Treatment Market by Type
10.1.5.1.2. The U.S. Gastroparesis Treatment Market by Drug Class
10.1.5.1.3. The U.S. Gastroparesis Treatment Market by Treatment
10.1.5.1.4. The U.S. Gastroparesis Treatment Market by Distribution Channel
10.1.5.2. Canada Gastroparesis Treatment Market
10.1.5.2.1. Canada Gastroparesis Treatment Market by Type
10.1.5.2.2. Canada Gastroparesis Treatment Market by Drug Class
10.1.5.2.3. Canada Gastroparesis Treatment Market by Treatment
10.1.5.2.4. Canada Gastroparesis Treatment Market by Distribution Channel
10.1.5.3. Mexico Gastroparesis Treatment Market
10.1.5.3.1. Mexico Gastroparesis Treatment Market by Type
10.1.5.3.2. Mexico Gastroparesis Treatment Market by Drug Class
10.1.5.3.3. Mexico Gastroparesis Treatment Market by Treatment
10.1.5.3.4. Mexico Gastroparesis Treatment Market by Distribution Channel
10.2. Europe
10.2.1. Europe Gastroparesis Treatment Market by Type
10.2.2. Europe Gastroparesis Treatment Market by Drug Class
10.2.3. Europe Gastroparesis Treatment Market by Treatment
10.2.4. Europe Gastroparesis Treatment Market by Distribution Channel
10.2.5. Europe Gastroparesis Treatment Market by Country
10.2.5.1. Germany Gastroparesis Treatment Market
10.2.5.1.1. Germany Gastroparesis Treatment Market by Type
10.2.5.1.2. Germany Gastroparesis Treatment Market by Drug Class
10.2.5.1.3. Germany Gastroparesis Treatment Market by Treatment
10.2.5.1.4. Germany Gastroparesis Treatment Market by Distribution Channel
10.2.5.2. United Kingdom Gastroparesis Treatment Market
10.2.5.2.1. United Kingdom Gastroparesis Treatment Market by Type
10.2.5.2.2. United Kingdom Gastroparesis Treatment Market by Drug Class
10.2.5.2.3. United Kingdom Gastroparesis Treatment Market by Treatment
10.2.5.2.4. United Kingdom Gastroparesis Treatment Market by Distribution Channel
10.2.5.3. France Gastroparesis Treatment Market
10.2.5.3.1. France Gastroparesis Treatment Market by Type
10.2.5.3.2. France Gastroparesis Treatment Market by Drug Class
10.2.5.3.3. France Gastroparesis Treatment Market by Treatment
10.2.5.3.4. France Gastroparesis Treatment Market by Distribution Channel
10.2.5.4. Italy Gastroparesis Treatment Market
10.2.5.4.1. Italy Gastroparesis Treatment Market by Type
10.2.5.4.2. Italy Gastroparesis Treatment Market by Drug Class
10.2.5.4.3. Italy Gastroparesis Treatment Market by Treatment
10.2.5.4.4. Italy Gastroparesis Treatment Market by Distribution Channel
10.2.5.5. Rest of Europe Gastroparesis Treatment Market
10.2.5.5.1. Rest of Europe Gastroparesis Treatment Market by Type
10.2.5.5.2. Rest of Europe Gastroparesis Treatment Market by Drug Class
10.2.5.5.3. Rest of Europe Gastroparesis Treatment Market by Treatment
10.2.5.5.4. Rest of Europe Gastroparesis Treatment Market by Distribution Channel
10.3. Asia Pacific
10.3.1. Asia Pacific Gastroparesis Treatment Market by Type
10.3.2. Asia Pacific Gastroparesis Treatment Market by Drug Class
10.3.3. Asia Pacific Gastroparesis Treatment Market by Treatment
10.3.4. Asia Pacific Gastroparesis Treatment Market by Distribution Channel
10.3.5. Asia Pacific Gastroparesis Treatment Market by Country
10.3.5.1. China Gastroparesis Treatment Market
10.3.5.1.1. China Gastroparesis Treatment Market by Type
10.3.5.1.2. China Gastroparesis Treatment Market by Drug Class
10.3.5.1.3. China Gastroparesis Treatment Market by Treatment
10.3.5.1.4. China Gastroparesis Treatment Market by Distribution Channel
10.3.5.2. Japan Gastroparesis Treatment Market
10.3.5.2.1. Japan Gastroparesis Treatment Market by Type
10.3.5.2.2. Japan Gastroparesis Treatment Market by Drug Class
10.3.5.2.3. Japan Gastroparesis Treatment Market by Treatment
10.3.5.2.4. Japan Gastroparesis Treatment Market by Distribution Channel
10.3.5.3. India Gastroparesis Treatment Market
10.3.5.3.1. India Gastroparesis Treatment Market by Type
10.3.5.3.2. India Gastroparesis Treatment Market by Drug Class
10.3.5.3.3. India Gastroparesis Treatment Market by Treatment
10.3.5.3.4. India Gastroparesis Treatment Market by Distribution Channel
10.3.5.4. South Korea Gastroparesis Treatment Market
10.3.5.4.1. South Korea Gastroparesis Treatment Market by Type
10.3.5.4.2. South Korea Gastroparesis Treatment Market by Drug Class
10.3.5.4.3. South Korea Gastroparesis Treatment Market by Treatment
10.3.5.4.4. South Korea Gastroparesis Treatment Market by Distribution Channel
10.3.5.5. Australia Gastroparesis Treatment Market
10.3.5.5.1. Australia Gastroparesis Treatment Market by Type
10.3.5.5.2. Australia Gastroparesis Treatment Market by Drug Class
10.3.5.5.3. Australia Gastroparesis Treatment Market by Treatment
10.3.5.5.4. Australia Gastroparesis Treatment Market by Distribution Channel
10.3.5.6. Rest of Asia-Pacific Gastroparesis Treatment Market
10.3.5.6.1. Rest of Asia-Pacific Gastroparesis Treatment Market by Type
10.3.5.6.2. Rest of Asia-Pacific Gastroparesis Treatment Market by Drug Class
10.3.5.6.3. Rest of Asia-Pacific Gastroparesis Treatment Market by Treatment
10.3.5.6.4. Rest of Asia-Pacific Gastroparesis Treatment Market by Distribution Channel
10.4. RoW
10.4.1. RoW Gastroparesis Treatment Market by Type
10.4.2. RoW Gastroparesis Treatment Market by Drug Class
10.4.3. RoW Gastroparesis Treatment Market by Treatment
10.4.4. RoW Gastroparesis Treatment Market by Distribution Channel
10.4.5. RoW Gastroparesis Treatment Market by Sub-region
10.4.5.1. Latin America Gastroparesis Treatment Market
10.4.5.1.1. Latin America Gastroparesis Treatment Market by Type
10.4.5.1.2. Latin America Gastroparesis Treatment Market by Drug Class
10.4.5.1.3. Latin America Gastroparesis Treatment Market by Treatment
10.4.5.1.4. Latin America Gastroparesis Treatment Market by Distribution Channel
10.4.5.2. Middle East Gastroparesis Treatment Market
10.4.5.2.1. Middle East Gastroparesis Treatment Market by Type
10.4.5.2.2. Middle East Gastroparesis Treatment Market by Drug Class
10.4.5.2.3. Middle East Gastroparesis Treatment Market by Treatment
10.4.5.2.4. Middle East Gastroparesis Treatment Market by Distribution Channel
10.4.5.3. Africa Gastroparesis Treatment Market
10.4.5.3.1. Africa Gastroparesis Treatment Market by Type
10.4.5.3.2. Africa Gastroparesis Treatment Market by Drug Class
10.4.5.3.3. Africa Gastroparesis Treatment Market by Treatment
10.4.5.3.4. Africa Gastroparesis Treatment Market by Distribution Channel
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/1382
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of gastroparesis treatment.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
Contact:
Infinium Global Research
2nd Floor, Ganadish Empire,
Rahatani Chowk, Pimple Saudagar,
Pimpri-Chinchwad, Maharashtra 411027
Phone: +918999930634
Email: Info@infiniumglobalresearch.com
Website: www.infiniumglobalresearch.com
Logo:https://mma.prnewswire.com/media/2244132/Infinium_Global_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-gastroparesis-treatment-market-is-expected-to-grow-revenue-up-to-usd-11-09-billion-by-2030-with-a-growing-cagr-of-3-3--infinium-global-research-301969999.html
